Viatris acquires Oyster Point Pharma and Famy Life Sciences

Acquisitions have the potential to add at least $1 billion in sales by 2028

Rupala to inaugurate 29 MVUs and centralised call center in Thiruvananthapuram

MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.

Sakar Healthcare starting Liquid & Lyophilised Injection unit

The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment

‘SMART’ program for Ayurveda professionals to boost research in Ayurveda

The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research

Mandaviya reviews arrangements for screening and testing of international passengers

Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test

Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences to consider raising Rs. 300 crores

USFDA grants appeal for Ardelyx's XPHOZAH

Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism

USFDA accepts for review the biologics license application for Pfizer’s Investigational MenABCWY in adolescents

If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine

Pfizer announces positive topline results from Phase 3 study of Hemophilia B gene therapy candidate

Hester to develop low pathogenic avian influenza inactivated vaccine for poultry

The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals